X

Xeris Biopharma Holdings

D
XERS
USD
0.005
(0.1486%)
Market Open
12,177.00
Volume
-0.325
EPS
-
Div Yield
-7.547619
P/E
482,756,193.00
Market Cap
Today
-6.0921%
1 Week
-2.318%
1 Month
8.034%
6 Months
67.196%
12 Months
68.984%
Year To Date
33.898%
All Time
0%

Title:
Xeris Biopharma Holdings

Sector:
Healthcare
Industry:
Biotechnology
Xeris Biopharma Holdings Inc is a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology. The company has three commercially available products, Gvoke, ready-to-use liquid glucagon for the treatment of severe hypoglycemia, Keveyis, the first FDA-approved therapy for primary periodic paralysis, and Recorlev, approved by the FDA for the treatment of endogenous hypercortisolemia in adult patients with Cushing's Syndrome. The Company also has a pipeline of development programs to bring new products forward using its proprietary formulation science, XeriSol and XeriJect.
Do you need help or have a question?